NUMI.V - Numinus Wellness Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.3700
+0.0150 (+4.23%)
At close: 3:52PM EDT
Stock chart is not supported by your current browser
Previous Close0.3550
Open0.3600
Bid0.3650 x N/A
Ask0.3700 x N/A
Day's Range0.3600 - 0.3850
52 Week Range0.3250 - 1.5500
Volume458,018
Avg. Volume1,820,193
Market Cap34.679M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1070
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Numinus announces Clinical Advisory Council to advance integrated wellness model
    CNW Group

    Numinus announces Clinical Advisory Council to advance integrated wellness model

    VANCOUVER, BC, June 24, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus") (TSX-V:NUMI.V - News) is pleased to announce its Clinical Advisory Council, chaired by Numinus Chief Medical Officer Dr. Evan Wood. "Our Clinical Advisory Council brings together scientific, mental health and clinical leaders to explore the potential of psychedelic assisted therapies in a safe, controlled therapeutic environment," says Dr. Wood.

  • CNW Group

    Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

    Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

  • CNW Group

    Dr. Devon Christie, MD CCFP RTC IFMCP, joins Numinus as Medical Director

    VANCOUVER, BC, June 3, 2020 /CNW/ - Dr. Evan Wood, Numinus Chief Medical Officer, today announced the appointment of Dr. Devon Christie, MD CCFP RTC IFMCP, to the position of Medical Director at Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV:NUMI.V - News) — another key step in the Company's evolution as a leader in the advancement of psychedelic therapies, treatment and research. "We are embarking on an exciting journey at Numinus," Dr. Wood says.

  • CNW Group

    Numinus Announces 2020 Operational Plans to Scale

    VANCOUVER , May 28, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus"), recently listed on the TSX Venture Exchange (NUMI.V), is pleased to report its near-term goals to advance our mission to address the universal desire to heal. For 2020, the company plans to upgrade its lab and processing facilities (for both cannabis and psychedelic substances), seek additional licences related to psychedelic substances and cannabis products, identify and build out a second wellness centre and develop psychedelic therapy protocols. Numinus believes the societal costs of mental illness, addictions, trauma and unmet human potential are much too high.

  • CNW Group

    Dr. Gabor Maté, recognised physician and bestselling author, joins Numinus as Member of the Clinical Advisory Council

    VANCOUVER, May 26, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus"; TSX-V: NUMI) is pleased to announce the appointment of Dr. Gabor Maté, MD, CM, as a Member of the Numinus Clinical Advisory Council. Through over 30 years' work in family practice, palliative care and addiction medicine, Dr. Maté has pioneered therapies and innovative, trauma-based approaches to mental health.

  • Numinus Virtually Opens The Market
    CNW Group

    Numinus Virtually Opens The Market

    TORONTO , May 21, 2020 /CNW/ -   https://www.youtube.com/watch?v=530qqxnrVgs Alongside team members, Payton Nyquvest , CEO and Founder of Numinus, joined Brady Fletcher , Managing Director & Head of TSX ...

  • CNW Group

    Dr. Evan Wood, recognized leader in the field of substance use research and treatment, joins Numinus as Chief Medical Officer

    VANCOUVER, May 21, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus") is pleased to announce the appointment of Dr. Evan Wood, MD, PhD, ABIM, FASAM, FRCPC, ABAM Diplomat as Chief Medical Officer with Numinus, effective immediately. Dr. Wood, who over a 20-year career has gained international recognition as a leading researcher into addiction, most recently as the Executive Director of the British Columbia Centre on Substance Use (BCCSU) — a leading research organization into the treatment of substance use and addiction. "This is an exciting day for all of us at Numinus," says Numinus CEO Payton Nyquvest.